Which Pharma Companies Have Spent the Most on Professional Print Ads through February 2016?

Gilead Healthcare

Gilead Healthcare remains in the top spot for pharma company advertising in professional health journals by dollars, according to Kantar Media. The company has 4.2% of the total advertising share while its next closest competitor, Johnson & Johnson, is very close behind with 4.0% of professional print ad dollars spent.

Top 5 Print Ad Pharma Companies (Dollars): YTD February 2016
  1. Gilead Healthcare – $3.9 MM (+55.5%)
  2. Johnson & Johnson – $3.8 MM (-26.3%)
  3. Lilly – $3.6 MM (+37.2%)
  4. Pfizer Corporate – $2.4 MM (+55.7%) 
  5. Amgen Inc – $2.2 MM (+25.1%)

The percentage changes compare January-February 2015 to January-February 2016. For more information on these ad insights or other data, let us know.

Kantar Media sets the standard for accurate, comprehensive competitive advertising intelligence in professional healthcare. Check back next month for updated data on the top products, classes, companies and category movers year-to-date.

  1. Pfizer – $17.1 MM (+8.2%)
  1. Pfizer – $17.1 MM (+8.2%)
  1. Pfizer – $17.1 MM (+8.2%)


Search article